✦ LIBER ✦

781 A randomized phase II trial of gemcitabine and either day 1 or day 8 carboplatin for advanced non-small cell lung cancer (NSCLC)

✍ Scribed by J. Iglesias; C. Crombie; W.I. Burns; C. Karapetis; R.M. Lowenthal; F. Kirsten; J.A. Davidson; F. Abell; W.H.H. Reece; P. DeSouza

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II trial of gemcitabine

✍ Cathy CROMBIE; W Ivon BURNS; Christos KARAPETIS; Ray M LOWENTHAL; Fred KIRSTEN; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

Gemcitabine-cisplatin (GP) vs gemcitabin

✍ P. Mazzanti; C. Massacesi; R. Mattioli; R. Trivisonne; F. Buzzi; G. De Signoribu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Docetaxel and Gemcitabine administered o

✍ Hirsh, Vera; Whittom, R.; Desjardins, P.; Laberge, F.; Latreille, J.; Samson, B. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Activity of gemcitabine and carboplatin

✍ Masotti, Alessandro; Zannini, Guido; Gentile, Alfonso; Morandini, Giancarlo 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Paclitaxel and carboplatin in combinatio

✍ Ceresoli, G.L; Favaretto, A; Paccagnella, A; Barbieri, F; Bearz, A; Schiavon, A. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB

A phase I/II trial of carboplatin and na

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 183 KB